Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does GEMCITABINE Cause Bronchopulmonary aspergillosis? 34 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Bronchopulmonary aspergillosis have been filed in association with GEMCITABINE (Gemcitabine). This represents 0.1% of all adverse event reports for GEMCITABINE.

34
Reports of Bronchopulmonary aspergillosis with GEMCITABINE
0.1%
of all GEMCITABINE reports
25
Deaths
30
Hospitalizations

How Dangerous Is Bronchopulmonary aspergillosis From GEMCITABINE?

Of the 34 reports, 25 (73.5%) resulted in death, 30 (88.2%) required hospitalization, and 9 (26.5%) were considered life-threatening.

Is Bronchopulmonary aspergillosis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for GEMCITABINE. However, 34 reports have been filed with the FAERS database.

What Other Side Effects Does GEMCITABINE Cause?

Off label use (3,319) Disease progression (3,123) Thrombocytopenia (2,320) Drug ineffective (2,003) Malignant neoplasm progression (1,962) Neutropenia (1,892) Anaemia (1,745) Pyrexia (1,511) Nausea (1,336) Myelosuppression (1,197)

What Other Drugs Cause Bronchopulmonary aspergillosis?

TACROLIMUS (968) PREDNISONE (967) DEXAMETHASONE (854) CYCLOPHOSPHAMIDE (824) METHYLPREDNISOLONE (794) PREDNISOLONE (704) MYCOPHENOLATE MOFETIL (702) RITUXIMAB (606) CYCLOSPORINE (583) METHOTREXATE (553)

Which GEMCITABINE Alternatives Have Lower Bronchopulmonary aspergillosis Risk?

GEMCITABINE vs GEMCITABINE\GEMCITABINE GEMCITABINE vs GEMFIBROZIL GEMCITABINE vs GEMTUZUMAB OZOGAMICIN GEMCITABINE vs GEMZAR GEMCITABINE vs GENTAMICIN

Related Pages

GEMCITABINE Full Profile All Bronchopulmonary aspergillosis Reports All Drugs Causing Bronchopulmonary aspergillosis GEMCITABINE Demographics